Lexology August 22, 2024
Questel

Navigating the complex regulatory compliance landscape in the life sciences sector is a formidable challenge, especially when dealing with medical devices and pharmaceutical translations. The European Union Medical Device Regulation (EUMDR) and In Vitro Diagnostic Regulation (IVDR) have introduced stringent requirements, making it more crucial than ever for companies to avoid common pitfalls. As the Director of Life Sciences Business Development, I have observed how these regulations impact our industry and the vital role of high-quality translation in achieving compliance.

Here, I’ll share ten tips to help you overcome these challenges and ensure your translations meet regulatory standards.

1. Understand the Regulatory Landscape

Before embarking on any translation project, it’s essential to understand the regulatory requirements of the target market...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, Regulations
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
Q&A: Generating data from neurons to teach AI the rules of the brain

Share This Article